SLN•benzinga•
Silence Therapeutics Q1 Collaboration Revenue £12.4M, Up £1M YoY; Cash Position £152.8M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 16, 2024 by benzinga